A Surprising Beneficiary of New Alzheimer’s Drugs: GE HealthCare
Biogen, Eli Lilly drugs will expand the imaging market for companies in the diagnostics space.
Biogen, Eli Lilly drugs will expand the imaging market for companies in the diagnostics space.
Healthcare is finally getting back to normal, which is good news for medical-device makers and hospitals, but not for insurers.
While GE HealthCare will deliver better growth as a stand-alone, the new company’s valuation looks stretched and its leverage is ...
Bio-Rad Laboratories is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth ...